PHILADELPHIA, Dec. 12, 2013 /PRNewswire/ -- Expanse Bioinformatics is pleased to announce that it has obtained a new patent, US Patent 8,606,761, entitled “Lifestyle Optimization and Behavior Modification” which was issued from the United States Patent & Trademark Office on December 10th, 2013. The Expanse portfolio now numbers twenty four patents, which will serve as a foundation for a company offering personalized medicine products.
The patent covers technology for using genetic information in combination with behavioral information which could allow consumers to receive meaningful results regarding how they can minimize the risk for disease by modifying their lifestyle based on their genetics. Expanse’s approach will provide real and meaningful answers to consumers on how to avoid disease through lifestyle modification and personalized treatment plans.
According to Dr. Charles Eldering, founder of Expanse Bioinformatics and a co-inventor of the technology, “The ‘761 patent represents a breakthrough in technology for providing specific recommendations for disease avoidance based on genetics, and avoids precisely the pitfalls plaguing 23andMe, a genetic testing service provider. The claimed technology is designed to allow companies to develop sound genetic based health recommendations that would likely meet regulatory requirement.”
For more information regarding Expanse Bioinformatics contact Dr. Charles Eldering at celdering@expansebio.com.
SOURCE Expanse Bioinformatics
Help employers find you! Check out all the jobs and post your resume.
